Erratum: Akt Mediates Metastasis-Associated Gene 1 (MTA1) Regulating the Expression of E-cadherin and Promoting the Invasiveness of Prostate Cancer Cells (PLoS ONE (2012) 7:12 (e46888) DOI: 10.1371/journal.pone.0046888);Akt Mediates Metastasis-Associated Gene 1 (MTA1) Regulating the Expression of E-cadherin and Promoting the Invasiveness of Prostate Cancer Cells

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Wang, Hongyan ^a,b   Fan, Liangsheng ^a,d   Wei, Juncheng ^a   Weng, Yanjie ^a   Zhou, Li ^c   Shi, Ying ^a   Zhou, Wenjuan ^a   Ma, Ding ^a   Wang, Changyu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHANDONG UNIVERSITY   (China)

^c Tianjin Key Laboratory of Human Development and Reproductive Regulation   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; SMALL INTERFERING RNA; TUMOR MARKER; UVOMORULIN; WORTMANNIN;

ARTICLE; CANCER CELL; CANCER CONTROL; CANCER INVASION; CANCER TISSUE; CELL ADHESION; CELL FUNCTION; CELL INVASION; CELL POLARITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; MOLECULAR MECHANICS; MTA1 GENE; PROSTATE CANCER; PROTEIN MODIFICATION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; TRANSURETHRAL RESECTION; UPREGULATION;

EID: 84870828422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0266930     Document Type: Erratum

References (50)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Toh Y, Nicolson GL, (2009) The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications. Clin Exp Metastasis 26: 215-227.
3. Geng L, Deepak PA, Aija L, Fuming C, Amanda M, et al. (2008) Identification of Metastasis Associated Antigen 1 (MTA1) by Serological Screening of Prostate Cancer cDNA Libraries. Open Biochem J 2: 100-107.
4. Hofer MD, Kuefer R, Varambally S, Li H, Ma J, et al. (2004) The role of metastasis-associated protein 1 in prostate cancer progression. Cancer Res 64: 825-829.
5. Toh Y, Pencil SD, Nicolson GL, (1994) A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269: 22958-22963.
6. Nicolson GL, Nawa A, Toh Y, Taniguchi S, Nishimori K, et al. (2003) Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation. Clin Exp Metastasis 20: 19-24.
7. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, et al. (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13: 1924-1935.
8. Manavathi B, Peng S, Rayala SK, Talukder AH, Wang MH, et al. (2007) Repression of Six3 by a corepressor regulates rhodopsin expression. Proc Natl Acad Sci U S A 104: 13128-13133.
9. Singh A, Settleman J, (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 29: 4741-4751.
10. Yilmaz M, Christofori G, (2009) EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 28: 15-33.
11. Moreno-Bueno G, Portillo F, Cano A, (2008) Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 27: 6958-6969.
12. Liu YN, Liu Y, Lee HJ, Hsu YH, Chen JH, (2008) Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis. Mol Cell Biol 28: 7096-7108.
13. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA, (2007) A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 13: 7003-7011.
14. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, et al. (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654.
15. Peinado H, Ballestar E, Esteller M, Cano A, (2004) Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 24: 306-319.
16. Federico A, Pallante P, Bianco M, Ferraro A, Esposito F, et al. (2009) Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. Cancer Res 69: 7079-7087.
17. Arzumanyan A, Friedman T, Kotei E, Ng IO, Lian Z, et al. (2010) Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer. Oncogene 31: 563-572.
18. Molli PR, Singh RR, Lee SW, Kumar R, (2008) MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene. Oncogene 27: 1971-1980.
19. Toh Y, Ohga T, Endo K, Adachi E, Kusumoto H, et al. (2004) Expression of the metastasis-associated MTA1 protein and its relationship to deacetylation of the histone H4 in esophageal squamous cell carcinomas. Int J Cancer 110: 362-367.
20. Pakala SB, Singh K, Reddy SD, Ohshiro K, Li DQ, et al. (2010) TGF-beta1 signaling targets metastasis-associated protein 1, a new effector in epithelial cells. Oncogene 30: 2230-2241.
21. Radaelli E, Damonte P, Cardiff RD, (2009) Epithelial-mesenchymal transition in mouse mammary tumorigenesis. Future Oncol 5: 1113-1127.
22. Rao Y, Wang H, Fan L, Chen G, (2011) Silencing MTA1 by RNAi reverses adhesion, migration and invasiveness of cervical cancer cells (SiHa) via altered expression of p53, and E-cadherin/beta-catenin complex. J Huazhong Univ Sci Technolog Med Sci 31: 1-9.
23. Cox AD, Der CJ, (2002) Ras family signaling: therapeutic targeting. Cancer Biol Ther 1: 599-606.
24. Fang J, Ding M, Yang L, Liu LZ, Jiang BH, (2007) PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal 19: 2487-2497.
25. Shimul S, Rajiv G, (2010) MTA1 Aids the AKT Pathway by Inhibiting Expression of a Key Regulator, PTEN. J Cancer Sci Ther 2: 114-119.
26. Larue L, Bellacosa A, (2005) Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 24: 7443-7454.
27. Grille SJ, Bellacosa A, Upson J, Klein-Szanto AJ, van Roy F, et al. (2003) The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178.
28. Yan W, Fu Y, Tian D, Liao J, Liu M, et al. (2009) PI3 kinase/Akt signaling mediates epithelial-mesenchymal transition in hypoxic hepatocellular carcinoma cells. Biochem Biophys Res Commun 382: 631-636.
29. Yang W, Luo D, Wang S, Wang R, Chen R, et al. (2008) TMTP1, a novel tumor-homing peptide specifically targeting metastasis. Clin Cancer Res 14: 5494-5502.
30. Wu M, Bai X, Xu G, Wei J, Zhu T, et al. (2007) Proteome analysis of human androgen-independent prostate cancer cell lines: variable metastatic potentials correlated with vimentin expression. Proteomics 7: 1973-1983.
31. Peyton SR, Ghajar CM, Khatiwala CB, Putnam AJ, (2007) The emergence of ECM mechanics and cytoskeletal tension as important regulators of cell function. Cell Biochem Biophys 47: 300-320.
32. Qian H, Lu N, Xue L, Liang X, Zhang X, et al. (2005) Reduced MTA1 expression by RNAi inhibits in vitro invasion and migration of esophageal squamous cell carcinoma cell line. Clin Exp Metastasis 22: 653-662.
33. Sasaki H, Yukiue H, Kobayashi Y, Nakashima Y, Kaji M, et al. (2001) Expression of the MTA1 mRNA in thymoma patients. Cancer Lett 174: 159-163.
34. Dannenmann C, Shabani N, Friese K, Jeschke U, Mylonas I, et al. (2008) The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO. Cancer Biol Ther 7: 1460-1467.
35. Tong D, Heinze G, Schremmer M, Schuster E, Czerwenka K, et al. (2007) Expression of the human MTA1 gene in breast cell lines and in breast cancer tissues. Oncol Res 16: 465-470.
36. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, et al. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826.
37. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83.
38. Kumar R, (2003) Another tie that binds the MTA family to breast cancer. Cell 113: 142-143.
39. Christofori G, Semb H, (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24: 73-76.
40. Katsamba P, Carroll K, Ahlsen G, Bahna F, Vendome J, et al. (2009) Linking molecular affinity and cellular specificity in cadherin-mediated adhesion. Proc Natl Acad Sci U S A 106: 11594-11599.
41. Hazan RB, Qiao R, Keren R, Badano I, Suyama K, (2004) Cadherin switch in tumor progression. Ann N Y Acad Sci 1014: 155-163.
42. Martin KC, Ephrussi A, (2009) mRNA localization: gene expression in the spatial dimension. Cell 136: 719-730.
43. Yao YL, Yang WM, (2003) The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem 278: 42560-42568.
44. Simpson A, Uitto J, Rodeck U, Mahoney MG, (2001) Differential expression and subcellular distribution of the mouse metastasis-associated proteins Mta1 and Mta3. Gene 273: 29-39.
45. Desai RA, Gao L, Raghavan S, Liu WF, Chen CS, (2009) Cell polarity triggered by cell-cell adhesion via E-cadherin. J Cell Sci 122: 905-911.
46. Shimul S, Rajiv G, (2010) MTA1 aids the AKT pathway by inhibiting expersssion of a key regulator, PTEN. J Cancer Sci Ther 2: 114-119.
47. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, et al. (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26: 7445-7456.
48. Luo J, Manning BD, Cantley LC, (2003) Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 4: 257-262.
49. Osaki M, Oshimura M, Ito H, (2004) PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9: 667-676.
50. De Santis G, Miotti S, Mazzi M, Canevari S, Tomassetti A, (2009) E-cadherin directly contributes to PI3K/AKT activation by engaging the PI3K-p85 regulatory subunit to adherens junctions of ovarian carcinoma cells. Oncogene 28: 1206-1217.